leading with local expertise
IPSUM applies the depth of our service offerings along with extensive therapeutic and analytical expertise to help our clients navigate the increasingly complex healthcare environment.
We work with biopharmaceutical companies with services and solutions that increase their probability of success, connecting insights with greater delivery for improved results.
We recruit and retain more engaged patients
“IPSUM is a leading SMO with local expertise covering patient recruitment, trial preparation, management and patient retention.
We recruit and retain more engaged patients, at fewer sites, and in less time than conventional trial sites, augmenting the quality and efficiency of our customers’ drug development pipeline. We have learned that, by engaging fully with patients, our clinical trials can be conducted more successfully and, in consequence, patient retention increases considerably. And because our clinical trial model is carefully applied throughout sites, we can offer clients consistent trials in all the country. One contract with IPSUM leads to large-scale patient recruitment with multiple sites to simplify trial management strategies.”
Site Management Services
We recruit and retain more engaged patients, at fewer sites, and in less time than conventional trial sites, augmenting the quality and efficiency of our customers’ drug development…
Clinical Research Services
Consulting and assistance for the complete design of clinical research documents in compliance with International Good Clinical Practices (GCP’s), and Standard Operation…
Ipsum provides services for medical device companies for companion software for their devices. Ipsum has worked with device makers on firmware development
We build durable, collaborative partnerships with our clients. It begins with a profound understanding of the challenges they face. We stay flexible and always look for proactive, responsible solutions to ensure client satisfaction. Working in close partnership, we ensure their goals become reality.